MLYS
Mineralys Therapeutics, Inc.
+0.77 (+2.80%)28.31USD496K成交股數2.5B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-10下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 221M | 24.4M | 31.5M | 38.3M | 37.9M | 44.6M | 54.0M | 39.3M | 30.8M | 22.5M | 11.9M | 12.3M |
| 銷售管理費用 | 24.7M | 21.0M | 9.7M | 8.5M | 6.6M | 7.2M | 6.1M | 5.9M | 4.6M | 3.8M | 3.9M | 2.6M |
| 營業利益 | −246M+454% | −45.3M-12% | −41.1M-32% | −46.7M+3% | −44.4M+26% | −51.8M+97% | −60.1M+282% | −45.2M+202% | −35.4M | −26.3M | −15.7M | −14.9M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −241M+471% | −39.3M-20% | −36.9M-34% | −43.3M+6% | −42.2M+34% | −48.9M+115% | −56.3M+364% | −41.0M+225% | −31.5M | −22.8M | −12.1M | −12.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -2.85+261% | -0.47-53% | -0.52-54% | -0.66-20% | -0.79+13% | -1.00+75% | -1.13+265% | -0.83+63% | -0.70 | -0.57 | -0.31 | -0.51 |
| 稀釋股數 | 84.7M | 82.8M | 70.6M | 65.5M | 53.2M | 48.5M | 49.8M | 49.4M | 44.9M | 39.9M | 39.8M | 24.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 138M | 113M | 218M | 102M | 165M | 114M | 97.3M | 67.9M | 90.4M | 86.3M | 101M | 138M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 668M | 653M | 600M | 336M | 355M | 206M | 268M | 318M | 347M | 278M | 291M | 306M |
| 有息負債 | 100K | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 117M | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 551M | 638M | 576M | 314M | 342M | 191M | 237M | 290M | 328M | 264M | 285M | 296M |
| 負債比 | 17.5% | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | 138M | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −39.5M | – | – | −45.5M+138% | – | – | – | −19.1M | – | – | −12.8M |
| 資本支出 | – | – | – | – | 0.00 | – | – | – | 59K | – | – | 0.00 |
| 自由現金流 | – | – | – | – | −45.5M+137% | – | – | – | −19.2M | – | – | −12.8M |
| 折舊攤銷 | – | 6K | – | – | 15K | – | – | – | 8K | – | – | 0.00 |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −155M | –% | -2.29 | −142M |
| FY2024 | – | – | −178M | –% | -3.66 | −166M |
| FY2023 | – | – | −71.9M | –% | -1.99 | −81.2M |
| FY2022 | – | – | −29.8M | –% | -5.77 | – |